LOHIA CORP LTD · QQ1 FY-2027 · THE CALL

Strong order book growth masks domestic revenue mix shift; margins held via pre-booked orders

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 results LCLLohia Corp Ltd27 Aug 2026 · 6 min read

Verdict

Hold

confidence 7/10

Credibility

Grade B

First call post-IPO; delivered numbers match stated results. Pre-COVID guidance (15-20% margins) confirmed in execution (19.9% Q1, 11.5% Q4). No prior numeric guidance to miss.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong order book visibility (₹1,778 Cr, 195% YoY growth) and delivered Q1 beat on revenue/PAT support the bullish case. However, execution risk (6-9 month cycles) and domestic revenue mix shift (70% of orders, only 59% of Q1 revenue) create near-term margin pressure that management is hedging rather than affirming. Hold until execution trajectory clears.

₹503 Cr

Revenue · +60% YoY

₹66.3 Cr

Reported PAT · +289.4% YoY

Expanding

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

EBITDA ₹100 Cr at 19.9% margin

MET

EBITDA ₹100 Cr (verified); OPM 19.9% matches reported

20% EBITDA margins sustainable going forward

MET

Achieved 19.9% in Q1 and 11.5% in Q1 FY26; pre-COVID range 15-20%

Order book ₹1,778 Cr up 30% since March 26

MET

Verified ₹1,778 Cr at end Q1 FY27; growth trajectory consistent

Exports revert to 50% of revenue going forward

OVERSTATED

Currently 41% of Q1 revenue; order book only 30% export. Assertion not yet evidenced

Domestic order book won't hurt margins due to pre-booked prices

Partial

Domestic now 70% of order book but only 59% of Q1 revenue—hedging on price contracts

Earnings quality

What changed since the last call

Deltas vs. the prior call

Order book composition shift

Downgrade

Domestic orders 70% of ₹1,778 Cr vs historical 41-50% exports. Margin impact hedged but not eliminated.

Capacity utilization clarity

Upgrade

Disclosed 70-72% current vs prior ambiguity. Runway to 85% and ₹2,500 Cr without major capex confirmed.

Margin guidance formalized

Neutral

Pre-COVID 15-20% range re-confirmed; 20% 'internally targeted', not formal. Cautious vs bullish framing.

The Q&A

Analysts pressed hard on margin sustainability (Harshit, Shreyansh), domestic mix headwind (Shreyansh), and order book peak risk (Kiran). Management held line on 20% margins via price discipline and pre-booked orders but did not boldly commit—caveats on geopolitics, raw material, competition conceded.

The exchanges that mattered

Order book composition — Kiran, Table Tree

Answered

Post-COVID investment recovery; non-packaging applications rising; single-use plastic ban driving demand. Not peak; peak yet to come.

Export margin sustainability — Shreyansh Talesara, Equentis

Partial

Operating leverage will play out; in export-heavy years EBITDA inches up; internally target 20%, no forward guidance.

Capacity runway — Akshay Satija, Alpha Invesco

Answered

80-85% peak; current ₹503 Cr at ~70% utilization suggests runway. Major capex needed beyond ₹2,500 Cr, not immediately planned.

Margin drivers — Harshit Patel, Equirus

Answered

Price revision per order; short/medium-term supplier contracts; discount structure tweaks. Three-pronged approach.

Chinese competition — Shivam Gupta, Trinetra

Answered

Yes, 15-20% premium due to service, reliability. China weak on service; India harder for them to break export.

Growth vs customer capex — Rishi Maheshwari, Aksa

Answered

Technical barrier in machine manufacturing. We have 2,000 customers globally; only 2-3 known suppliers worldwide.

R&D and new products — Arvind Arora, A Square

Partial

3% to remain average. Confidential automation/IoT developments underway. 3% maintained going forward.

Replacement cycle — Prince Choudhary, Pinc Wealth

Partial

Majority expansion (new). 3-5% replacement. Globally, 25 years of exports now hitting replacement. Quantification difficult.

Guidance

Forward guidance and management's confidence

FY27 revenue growth 20-25% range

Medium

Based on rising non-packaging applications and customer capex expansion. Order book ₹1,778 Cr supports base.

EBITDA margin 20% internally targeted

Medium

Not formal guidance; achieved in Q1 FY27 (19.9%) and Q4 FY26 (11.5% stated as comparison). Pre-COVID norm 15-20%.

Major capex only beyond ₹2,500 Cr turnover

High

Current ₹503 Cr at 70% utilization can grow to ₹2,400-2,500 Cr. Capex deployment 5-6 months once approved.

Risks the call surfaced

Ranked by how much they should concern a holder

Order execution timing

Medium

₹1,778 Cr order book executed over 6-9 months means backend loading. Q2-Q3 ramp-up execution risk.

Domestic revenue concentration

Medium

70% of order book now domestic vs 59% of Q1 revenue. If domestic margin lower and repricing delayed, margins compress.

Export order recovery delay

Medium

Management expects exports to revert to 45-55% (50%) of revenue, but currently only 30% of order book. Timing unclear.

Geopolitical & commodity volatility

Medium

Management cited wars, China supply decisions, raw material movement as margin headwinds. Macro uncertainty not controllable.

Chinese competition and pricing power

Low

15-20% premium over China maintained today, but if downturn arrives, premium could compress.

Management

Score 7/10. Transparent on challenges (domestic mix shift, geopolitical risks, margin hedging) but cautious on forward commitments. Pre-IPO listing first call shows discipline. Delivered Q1 results match stated numbers exactly. Order book growth sustained (195% YoY) and operational improvements (EBITDA +276%) executed.

What to watch next

1 · Q2 FY27
Order execution ramp; domestic mix revenue impact on margins
2 · H2 FY27
Export order book reversal from 30% to 50% (if management thesis holds)
3 · FY28
Capacity expansion capex (₹80-100 Cr) if revenue hits ₹2,500 Cr

Hold until execution trajectory clears.

Informational and educational content only. Not investment advice.